奥美拉唑和泮托拉唑在反流性食管炎中的成本效果观察  

The Effect Observation of Omeprazole and Pantoprazole in Reflux Esophagitis

作　　者：佘子岳[1] 刘学功[1] 

机构地区：[1]中山大学附属第五医院,广东中山519000

出　　处：《中国医药指南》2014年第26期13-13,15,共2页Guide of China Medicine

摘　　要：目的比较分析奥美拉唑和泮托拉唑在反流性食管炎中的成本效果差异性。方法回顾性分析我院2012年1月至2014年1月收治的85例反流性食管炎患者的临床资料,根据治疗方法不同,将患者分为2组,奥美拉唑组和泮托拉唑组,两组患者疗程结束后比较成本效果差异。结果奥美拉唑组42例患者,治疗总有效率为90.48%,泮托拉唑组43例患者,治疗总有效率为93.02%,略高于奥美拉唑组,经比较,P>0.05,无显著性差异。奥美拉唑组的C/E值为4.99,明显小于泮托拉唑组,说明奥美拉唑组患者的治疗成本效果较好。结论采用国产奥美拉唑肠溶片治疗反流性食管炎具有相对的成本效果优势,是较为理想的治疗方案。Objective To compare the analysis of omeprazole and pantoprazole in reflux esophagitis affect difference. Methods A retrospective analysis of our hospital between January 2012 and January 2014, 85 cases of reflux esophagitis patients clinical data, according to different therapeutic methods, divided the patients into two groups, omeprazole group and pantoprazole groups, two groups of patients after the treatment effect of comparative cost differences. Results Omeprazole group of 42 patients, treatment the total effective rate was 90.48%, pantoprazole groups of 43 patients, treatment the total effective rate was 93.02%, slightly higher than that of omeprazole group, by comparison, P〈0.05, no significant difference. Omeprazole group C/E value is 4.99, much smaller than pantoprazole groups, suggests that the treatment of patients with omeprazole group cost effect is well. Conclusion The domestic omeprazole enteric-coated tablets in treatment of reflux esophagitis have relative cost effect advantage, is the ideal treatment.

关 键 词：奥美拉唑 泮托拉唑 反流性食管炎 

分 类 号：R571[医药卫生—消化系统]